Non-Hodgkin Lymphoma Therapeutics

Global Market Trajectory & Analytics

MCP13614

EXECUTIVE ENGAGEMENTS

OUTREACH

4623
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

833
Interactions with Platform & by Email

PARTICIPANTS

139
Unique # Participated

VALIDATIONS

42
Responses Validated*

COMPETITORS

38
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

57

PAGES

125

EDITION

6

PRICE

USD $4950


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Non-Hodgkin Lymphoma Therapeutics estimated at US$5.4 Billion  in the year 2020, is projected to reach a revised size of US$8.1 Billion  by 2027, growing at a CAGR of 6% over the analysis period 2020-2027. Chemotherapy, one of the segments analyzed in the report, is projected to record a 6% CAGR and reach US$3.6 Billion  by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Targeted segment is readjusted to a revised 6.8% CAGR for the next 7-year period.
The Non-Hodgkin Lymphoma Therapeutics market in the U.S. is estimated at US$1.6 Billion  in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion  by the year 2027 trailing a CAGR of 5.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.6% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.
In the global Radiation Therapy segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.4 Billion  in the year 2020 will reach a projected size of US$2.1 Billion  by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$932.5 Million  by the year 2027.

SELECT PLAYERS

Bayer AG; Bristol-Myers Squibb Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.

SEGMENTS

» Therapeutics (Chemotherapy, Targeted, Radiation Therapy)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com